# Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant Chemotherapy in Early Stage NSLC

> **NCT00321334** · PHASE3 · COMPLETED · sponsor: **Chinese Society of Lung Cancer** · enrollment: 410 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **PROCEDURE:** Chemotherapy+Surgery

## Key facts

- **NCT ID:** NCT00321334
- **Lead sponsor:** Chinese Society of Lung Cancer
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 410 (ACTUAL)
- **Last updated:** 2014-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00321334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00321334, "Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant Chemotherapy in Early Stage NSLC". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00321334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*